News GSK/Janssen's rheumatoid arthritis drug filed in EU Drug could compete against Sanofi rival if approved.
News Novartis Breezhaler bests GSK's Seretide in COPD Ultibro showed consistent reductions in rate of all exacerbations, whether mild, moderate, or severe.
News GSK and Alphabet launch bioelectronic medicines firm Galvani will combine Google tech knowhow with GSK's life science expertise.
News UK could quit EU drug regulation system - minister Nothing has been ruled in or out, says George Freeman.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
